Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-013192

STEMLINE THERAPEUTICS INC · STML

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David Gionco
Officer — Chief Accounting Officer
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 9:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Feb 27, 2017S3,500$6.97D99,892D
Common StockF1,F4,F5Feb 28, 2017S2,986$7.01D96,906D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses